As an unexpected finding a dose-response analysis of the BPH patient subcohort suggested a significant trend in reduction of CVD risk with greater use of 5ARI, with the highest tertile of 5ARI users experiencing significant risk reduction referent to non-users.
← all excerpts
Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men.
1
—
—